Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario
Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available. Aim: To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients and Me...
Guardado en:
Autores principales: | , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2016
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000800002 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872016000800002 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720160008000022016-12-21Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinarioPeña,PedroZagolin,MónicaAcuña,MónicaNavarrete,SandraBustamante,PilarCanals,Andrea Tobacco Tobacco Use Cessation Tobacco Use disorder Varenicline Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available. Aim: To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients and Methods: Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program. Results: The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction level of more than 12 years was associated with a lower failure rate (OR 0.38 95% CI 0.18-0.82). Conclusions: A high tobacco dependence rate and a lower education were associated with a higher failure rate of this smoking cessation program.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.144 n.8 20162016-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000800002es10.4067/S0034-98872016000800002 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Tobacco Tobacco Use Cessation Tobacco Use disorder Varenicline |
spellingShingle |
Tobacco Tobacco Use Cessation Tobacco Use disorder Varenicline Peña,Pedro Zagolin,Mónica Acuña,Mónica Navarrete,Sandra Bustamante,Pilar Canals,Andrea Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
description |
Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available. Aim: To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients and Methods: Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program. Results: The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction level of more than 12 years was associated with a lower failure rate (OR 0.38 95% CI 0.18-0.82). Conclusions: A high tobacco dependence rate and a lower education were associated with a higher failure rate of this smoking cessation program. |
author |
Peña,Pedro Zagolin,Mónica Acuña,Mónica Navarrete,Sandra Bustamante,Pilar Canals,Andrea |
author_facet |
Peña,Pedro Zagolin,Mónica Acuña,Mónica Navarrete,Sandra Bustamante,Pilar Canals,Andrea |
author_sort |
Peña,Pedro |
title |
Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
title_short |
Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
title_full |
Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
title_fullStr |
Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
title_full_unstemmed |
Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
title_sort |
factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario |
publisher |
Sociedad Médica de Santiago |
publishDate |
2016 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000800002 |
work_keys_str_mv |
AT penapedro factoresasociadosconelexitodelaterapiaantitabacoenpacientestratadosconvareniclina10anosdeexperienciaenunprogramamultidisciplinario AT zagolinmonica factoresasociadosconelexitodelaterapiaantitabacoenpacientestratadosconvareniclina10anosdeexperienciaenunprogramamultidisciplinario AT acunamonica factoresasociadosconelexitodelaterapiaantitabacoenpacientestratadosconvareniclina10anosdeexperienciaenunprogramamultidisciplinario AT navarretesandra factoresasociadosconelexitodelaterapiaantitabacoenpacientestratadosconvareniclina10anosdeexperienciaenunprogramamultidisciplinario AT bustamantepilar factoresasociadosconelexitodelaterapiaantitabacoenpacientestratadosconvareniclina10anosdeexperienciaenunprogramamultidisciplinario AT canalsandrea factoresasociadosconelexitodelaterapiaantitabacoenpacientestratadosconvareniclina10anosdeexperienciaenunprogramamultidisciplinario |
_version_ |
1718436897118748672 |